CAT - catalase Gene

Homo sapiens

Gene ID: 847 | Gene type: protein coding

About CAT

Cytogenetic location: 11p13 Genomic coordinates (GRCh38): 11:34,438,934-34,472,060 (from NCBI)

This gene has 6 transcripts (splice variants), 240 orthologues and is associated with 2 phenotypes. Broad expression in liver (RPKM 283.8), fat (RPKM 207.7) and 23 other tissues.

Summary

This gene encodes catalase, a key antioxidant Enzyme in the bodies defense against oxidative stress. Catalase is a heme Enzyme that is present in the peroxisome of nearly all aerobic cells. Catalase converts the Reactive Oxygen Species hydrogen peroxide to water and oxygen and thereby mitigates the toxic effects of hydrogen peroxide. Oxidative stress is hypothesized to play a role in the development of many chronic or late-onset diseases such as diabetes, asthma, Alzheimer's disease, systemic lupus erythematosus, rheumatoid arthritis, and cancers. Polymorphisms in this gene have been associated with decreases in catalase activity but, to date, acatalasemia is the only disease known to be caused by this gene. [provided by RefSeq, Oct 2009]

CAT Products(1)

mRNA	Protein	Name
NM_001752.4	NP_001743.1	catalase

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	Reference	Source
enables NADP binding	IDA IDA: Inferred from direct assay	10656833	GOA
enables antioxidant activity	IDA IDA: Inferred from direct assay	10514471	GOA
enables catalase activity	IDA IDA: Inferred from direct assay	7882369	GOA
enables enzyme binding	IPI IPI: Inferred from physical interaction	16781659	GOA
enables heme binding	IDA IDA: Inferred from direct assay	10656833	GOA
enables identical protein binding	IPI IPI: Inferred from physical interaction	21976670	GOA
enables protein homodimerization activity	IDA IDA: Inferred from direct assay	10656833	GOA

Biological Process GO Annotation	Evidence	Reference	Source
involved in UV protection	IMP IMP: Inferred from mutant phenotype	16644728	GOA
involved in cellular detoxification of hydrogen peroxide	IDA IDA: Inferred from direct assay	18379038	GOA
involved in hydrogen peroxide catabolic process	IDA IDA: Inferred from direct assay	18379038	GOA
involved in negative regulation of apoptotic process	IMP IMP: Inferred from mutant phenotype	16644728	GOA
involved in response to reactive oxygen species	IMP IMP: Inferred from mutant phenotype	16644728	GOA

Cellular Component GO Annotation	Evidence	Reference	Source
part of catalase complex	IPI IPI: Inferred from physical interaction	10656833	GOA
is active in peroxisome	IDA IDA: Inferred from direct assay	8769411	GOA
located in peroxisome	IDA IDA: Inferred from direct assay	2895531	GOA
part of protein-containing complex	IPI IPI: Inferred from physical interaction	21976670	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CAT Protein Structure

Catalase

Catalase-rel

0
100
200
300
400
527 a.a.

Protein Preferred Names

Protein Names

catalase

epididymis secretory sperm binding protein

Recombinant CAT Proteins

Cat. No.	Product Name	Accession	Purity
HY-P7744	Catalase Protein, Human	P04040 (A2-L527)	≥95%
HY-P7744A	Catalase Protein, Human (His)	P04040 (A2-L527)	≥95%

Related Diseases

Diseases

Alias

Acatalasemia

Acatalasia	Catalase Deficiency
Deficiency Of Catalase	ACATLAS
Takahara'S Disease	Takahara Disease

Pityriasis Versicolor

Tinea Versicolor

Infection By Pityrosporum Furfur

Acne

Acne Vulgaris	Acne Varioliformis
Frontalis Acne

Peroxisome Biogenesis Disorder 1b

Peroxisome Biogenesis Disorder	Infantile Refsum Disease
Infantile Phytanic Acid Storage Disease	PBD1B
Refsum Disease, Infantile	Adrenoleukodystrophy, Autosomal Neonatal
Ird	Mild Pbd-Zsd
Mild Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder	Pbd-Zsd
Peroxisome Biogenesis Disorder Spectrum	Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder
Autosomal Neonatal Adrenoleukodystrophy	Refsum Disease Infantile
Peroxisome Biogenesis Disorders	Peroxisome Biogenesis Disorder, Type 1b

Neonatal Adrenoleukodystrophy

Nald	Adrenoleukodystrophy Autosomal Neonatal Form
Intermediate Pbd-Zsd	Intermediate Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder
Adrenoleukodystrophy, Autosomal, Neonatal Form	Adrenoleukodystrophy Neonatal
Adrenoleukodystrophy, Neonatal

Diabetic Angiopathy

Diabetic Angiopathies	Diabetic Peripheral Angiopathy
Diabetic Vascular Disorder

Chronic Granulomatous Disease

Cgd	Granulomatous Disease, Chronic
Autosomal Recessive Chronic Granulomatous Disease	X-Linked Chronic Granulomatous Disease
Bridges-Good Syndrome	Congenital Dysphagocytosis
Quie Syndrome	Chronic Septic Granulomatosis
Chronic Granulomatous Disorder	Granulomatous Disease Chronic
Granulomatous Disease, Chronic, X-Linked

Zellweger Syndrome

Cerebrohepatorenal Syndrome	Zellweger Leukodystrophy
Zs	Congenital Iron Overload
Chr	Zws
Severe Pbd-Zsd	Severe Peroxisome Biogenesis Disorder-Zellweger Spectrum Disorder

Erysipelas

Hemosiderosis

Haemosiderosis

Iron Overload

Myeloperoxidase Deficiency

Mpo Deficiency

MPOD

Asbestosis

Idiopathic Interstitial Pneumonitis - From Asbestos Exposure

Pulmonary Fibrosis - From Asbestos Exposure

Peroxisomal Disease

Peroxisomal Disorder	Peroxisomal Disorders
Peroxisomal Defects

Cryptosporidiosis

Cryptosporidial Gastroenteritis	Intestinal Cryptosporidiosis
Infection By Cryptosporidium	Gastroenteritis Due To Cryptosporidium
Cryptosporidial Infection

Pneumoconiosis

Pneumoconioses	Silicosis Nos
Complicated Silicosis	Fibrosis Of Lung With Silicosis
Nodular Silicosis	Pneumoconiosis Due To Silica
Silicotic Fibrosis Of Lung	Simple Silicosis
Silicatosis	Silicotic Lung Fibrosis
Pneumoconiosis Due To Talc	Pulmonary Talcosis
Talc Lung Disease	Talc Pneumoconiosis
Talc Workers' Pneumoconiosis	Talcosis
Fibrosis Of Lung Due To Talc	Asbestos Pneumoconiosis
Amianthosis	Asbestosis
Lung Fibrosis With Asbestosis	Pulmonary Asbestosis

Maple Syrup Urine Disease

MSUD	Bckd Deficiency
Branched-Chain Ketoaciduria	Branched-Chain Alpha-Keto Acid Dehydrogenase Deficiency
Keto Acid Decarboxylase Deficiency	Maple Syrup Urine Disease, Type Ii
Branched Chain Ketoaciduria	Classic Maple Syrup Urine Disease
Intermittent Maple Syrup Urine Disease	Maple Syrup Urine Disease, Type Ia
Ketoacidaemia	Bckdh Deficiency
Branched-Chain 2-Ketoacid Dehydrogenase Deficiency	Thiamine-Responsive Maple Syrup Urine Disease
Intermediate Maple Syrup Urine Disease	Maple Syrup Urine Disease Type 1a
Maple Syrup Urine Disease Type 1b	Maple Syrup Urine Disease Type 2
Maple Syrup Urine Disease, Type Ib	Dihydrolipoamide Dehydrogenase Deficiency
Branched-Chain Ketoacid Dehydrogenase Deficiency	Maple Syrup Disease
Ketoacidemia	Classic Bckd Deficiency
Classic Msud	Classic Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency
Classic Branched-Chain Ketoaciduria	Thiamine-Responsive Bckd Deficiency
Thiamine-Responsive Msud	Thiamine-Responsive Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency
Intermittent Bckd Deficiency	Intermittent Msud
Intermittent Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency	Maple Syrup Urine Disease 1a
MSUD1A	Maple Syrup Urine Disease Type Ia
Msud Type Ia	Maple Syrup Urine Disease 1b
MSUD1B	Maple Syrup Urine Disease Type Ib
Msud Type Ib	Maple Syrup Urine Disease 2
MSUD2	Maple Syrup Urine Disease Type Ii
Msud Type Ii	Nadh Cytochrome B5 Reductase Deficiency
Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency	Ketonemia
Maple Syrup Urine Disease, Type 1b	Ketoacid Decarboxylase Deficiency
Oxoacid Decarboxylase Deficiency	Branched Chain Ketoacid Dehydrogenase Deficiency
Msud - [Maple-Syrup-Urine Disease]	Ketoaminoacidaemia
Bckd - [Branched-Chain Alpha-Ketoacid Dehydrogenase Deficiency]	Maple-Syrup-Urine Disorder
Maple-Syrup-Urine Syndrome

Bacteriuria

Asthma

Chronic Obstructive Asthma	Asthma, Diminished Response To Antileukotriene Treatment In
Bronchial Hyperreactivity	Asthma, Susceptibility To
Asthma, Bronchial	Asthma, Protection Against
Asthma, Nocturnal, Susceptibility To	Nocturnal Asthma
Asthma-Related Traits	Asthma-Related Traits, Susceptibility To
Asthma, Nocturnal	Chronic Obstructive Asthma With Acute Exacerbation
Chronic Obstructive Asthma With Status Asthmaticus	Exercise Induced Asthma
Exercise-Induced Asthma	Bronchial Asthma
Asthma, Exercise-Induced	Idiosyncratic Asthma
Unspecified Asthma With Acute Exacerbation	Asthma, Unspecified, With Stated Status Asthmaticus
Status Asthmaticus Nos	Acute Severe Asthma
Acute Severe Bronchial Asthma	Status Asthma
Status Post Asthmaticus

Rhizomelic Chondrodysplasia Punctata

Chondrodysplasia Punctata, Rhizomelic	Rcdp
Chondrodysplasia Punctata, Rhizomelic Form	Rcp
Chondrodysplasia Punctata Rhizomelic

Iron Deficiency Anemia

Iron-Deficiency Anemia	Fe Deficiency Anaemia
Ida - [Iron Deficiency Anemia]	Fe - [Iron] Deficiency Anemia Nos

Syphilis

Chancre

Syphilitic Chancre

Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1

Vitiligo	VAMAS1
Slev1	Vtlg
Systemic Lupus Erythematosus, Vitiligo-Related	Vitiligo-Associated Multiple Autoimmune Disease 1
Systemic Lupus Erythematosus Vitiligo-Related

Atrophic Gastritis

Gastritis, Atrophic	Gastric Atrophy
Gastritis Atrophic

Refsum Disease, Classic

Refsum Disease	Heredopathia Atactica Polyneuritiformis
Phytanic Acid Oxidase Deficiency	Hmsn Iv
Refsum Disease, Adult, 1	Refsum'S Disease
Phytanic Acid Storage Disease	Hereditary Motor And Sensory Neuropathy Iv
Hmsn4	Hmsn Type Iv
Hmsn 4	Adult Refsum Disease
Classic Refsum Disease	Hereditary Motor And Sensory Neuropathy Type Iv
Refsum Syndrome	Hsmn Iv
Disorder Of Cornification 11	Doc 11
Hereditary Sensory And Motor Neuropathy Type 4	Hypertrophic Neuropathy Of Refsum
Ard	Crd
Hereditary Motor And Sensory Neuropathy Type 4	Phytanic-Coa Hydroxylase Deficiency
RD

Rheumatoid Arthritis

RA	Arthritis, Rheumatoid
Rheumatoid Arthritis, Susceptibility To	Arthritis Or Polyarthritis, Rheumatic
Atrophic Arthritis	Rheumatism Arthritis
Rheumatoid Polyarthritis

Systemic Lupus Erythematosus

Lupus Nephritis	SLE
Disseminated Lupus Erythematosus	Systemic Lupus Erythematosus, Susceptibility To
Lupus Erythematosus, Systemic	Lupus Nephritis, Susceptibility To
Libman-Sacks Disease	Systemic Lupus Erythematosus Susceptibility To
Sle - Lupus Erythematosus, Systemic	Le Syndrome
Lupus	Lupus Erythematosus Systemic
Lupus Erythematosus, Systemic, Susceptibility To	Lupus Vulgaris
Lupus Erythematosus, Discoid	Lupus Erythematosus
Systemic Lupus Erythematosus Nos	Sle - [Systemic Lupus Erythematosus]

Diabetes Mellitus

Diabetes

Male Infertility

Infertility, Male	Infertility Male
Male Sterility	Absolute Infertility

Glycogen Storage Disease

Glycogenosis	Glycogenoses
Gsd	Storage Disease, Glycogen
Gsd - [Glycogen Storage Disease]	Glycogen Thesaurismosis
Diffuse Glycogenosis	Generalised Glycogen Storage Disease
Generalised Glycogenosis	Generalised Glycogen Storage Disease Of Infants
Glycogen Synthase Deficiency

Melanoma

Malignant Melanoma	Cutaneous Melanoma
Naevocarcinoma	Malignant Melanomas

Tetralogy Of Fallot

TOF	Fallot Tetralogy
Ventricular Septal Defect With Pulmonary Stenosis Or Atresia, Dextraposition Of Aorta, And Hypertrophy Of Right Ventricle	Tetrad Of Fallot
Fallot Tetrad	Fallot Disease
Fallot Complex	Subpulmonic Stenosis, Ventricular Septal Defect, Overriding Aorta, And Right Ventricular Hypertrophy
Interventricular Septal Defect With Dextroposition Of Aorta, Pulmonary Stenosis And Hypertrophy Of Right Ventricle	Interventricular Septal Defect, In Tetralogy Of Fallot
Ventricular Septal Defect With Obstructed Right Ventricular Outflow	Tof - [Tetralogy Of Fallot]
Pulmonary Atresia With Ventricular Septal Defect [Fallot Type]	Pulmonary Atresia, Ventricular Septal Defect And Mapcas
Pulmonary Atresia With Ventricular Septal Defect And Systemic-To-Pulmonary Collateral Arteries [Fallot Type]

Constipation

Skin Disease

Skin Diseases	Genodermatosis
Abnormality Of The Skin	Skin Diseases, Genetic
Skin And Subcutaneous Tissue Disease	Dermatologic Disorders

Bacteremia 2

Bacteremia	Bacteremia, Susceptibility To, 2
BACTS2	Bacteremia, Susceptibility To
Bacteremia, Susceptibility To, Type 2

Type 2 Diabetes Mellitus

Insulin Resistance	NIDDM
Type 2 Diabetes	Diabetes Mellitus, Non-Insulin-Dependent
T2D	Noninsulin-Dependent Diabetes Mellitus
Diabetes Mellitus, Type Ii	Maturity-Onset Diabetes
Insulin Resistance, Severe, Digenic	Diabetes Mellitus, Type 2
Diabetes Mellitus, Noninsulin-Dependent	Diabetes Mellitus, Noninsulin-Dependent, Association With
Diabetes Mellitus, Noninsulin-Dependent, Late Onset	Hypertension, Insulin Resistance-Related, Susceptibility To
Insulin Resistance, Susceptibility To	Non-Insulin-Dependent Diabetes Mellitus
Type Ii Diabetes Mellitus	Adult-Onset Diabetes Mellitus
Maturity-Onset Diabetes Mellitus	Diabetes Mellitus Type 2
Type Ii Diabetes	Type 2 Diabetes Mellitus, Susceptibility To
Diabetes, Type 2	Diabetes Mellitus, Noninsulin-Dependent, Susceptibility To
Diabetes Mellitus, Non-Insulin-Dependent, Susceptibility To	Diabetes Mellitus, Type 2, Susceptibility To
Diabetes Mellitus, Noninsulin-Dependent, 2	Diabetes Mellitus, Type Ii, Susceptibility To
Hypertension, Insulin Resistance-Related	Adult-Onset Diabetes
Aodm	Diabetes Mellitus, Adult-Onset
Diabetes Mellitus Type Ii	Diabetes Mellitus Type 2, Susceptibility To
Diabetes, Type Ii, Susceptibility To	Diabetes Type 2
Diabetes Mellitus	Adult Onset Diabetes
Maturity Onset Diabetes	Nonketotic Diabetes
Non-Insulin Dependent Diabetes Mellitus	T2dm - [Type 2 Diabetes Mellitus]
Niddm - [Non Insulin Dependent Diabetes Mellitus]	Dm2
Dm Type Ii	Diabetic Type 2
Insulin Requiring Type 2 Diabetes	Noninsulin Dependent Diabetes
Non-Insulin-Dependent Diabetes Mellitus Without Complications	Diabetes Due To Insulin Secretory Defect
Diabetes Mellitus Due To Insulin Secretory Defect	Non-Insulin-Dependent Diabetes Of The Young
Senile Diabetes	Nonketotic Hyperglycaemia
Stable Diabetes

Motor Neuron Disease

Anterior Horn Cell Disease	Motor Neuron Diseases
Mnd - [Motor Neurone Disease]	Lou Gehrig Disease
Creeping Palsy	Creeping Paralysis
Bulbar Motor Neuron Disease	Bulbar Syndrome
Anterior Horn Cell Disorder	Hereditary Motor Neuron Disease

Cerebral Palsy

Infantile Cerebral Palsy	Mixed Cerebral Palsy
Palsy Cerebral	Palsy, Cerebral
Cerebral Palsy, Mixed

Acute Promyelocytic Leukemia

Leukemia, Acute Promyelocytic	Acute Myeloblastic Leukemia Type 3
Aml M3	APL
Leukemia, Acute Promyelocytic, Somatic	Aml With T(15
17)(Q22	Q12)
(Pml/Raralpha) And Variants	Apml
Acute Myeloblastic Leukemia 3	Acute Myeloid Leukemia With T(15
17)(Q22	Q12)
(Pml/Raralpha) And Variants	Acute Myeloblastic Leukaemia Type 3
Acute Myeloid Leukaemia M3	Acute Myeloid Leukemia M3
Acute Promyelocytic Leukaemia	M3 Anll
Myeloid Leukemia, Acute, M3	Leukemia Promyelocytic Acute
Leukemia, Promyelocytic, Acute	Leukemia, Acute, Promyelocytic

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval

Bioactive Molecules (23)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0988	Deferoxamine mesylate		99.86%	Unkown
HY-Y0682	Ethylenediaminetetraacetic acid		≥98.0%	Unkown
HY-B1625	Deferoxamine		99.76%	Yes
HY-B0193A	Prazosin hydrochloride		99.86%	Unkown
HY-B1221	Flufenamic acid		99.93%	Unkown
HY-P0163	Gramicidin	Inhibitor	≥98.0%	Unkown
HY-75161	(-)-Menthol	Activator	99.79%	Unkown
HY-B1836	Meldonium	Activator	99.82%	Unkown
HY-B1213	Trimipramine maleate		99.82%	Unkown
HY-Y0682B	Ethylenediaminetetraacetic acid tetrasodium		≥98.0%	Unkown
HY-109556	Insulin Detemir	Activator	≥95.0%	Unkown
HY-119572	Sodium zirconium cyclosilicate		≥95.0%	Unkown
HY-Y0682A	Ethylenediaminetetraacetic acid disodium dihydrate		≥98.0%	Unkown
HY-B0565	Ronidazole	Inhibitor	99.79%	Unkown
HY-B1836A	Meldonium dihydrate	Activator	≥99.0%	Unkown
HY-103354	Proglumide sodium	Antagonist	99.85%	Yes
HY-B1330	Proglumide	Antagonist	99.74%	Yes
HY-B1009	Ethylenediaminetetraacetic acid trisodium salt		≥98.0%	Unkown
HY-118874	Oblimersen		/	Unkown
HY-103354A	Proglumide hemicalcium	Antagonist	/	Unkown
HY-16094	Bethanidine sulfate	Antagonist	/	Unkown
HY-B0193AR	Prazosin hydrochloride (Standard)		/	Unkown
HY-B1213A	Trimipramine		/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99255	Moxetumomab pasudotox	Inhibitor	/	Unkown

Clinical Phase

Bioactive Molecules (15)

Cat. No.	Product Name	Effect	Purity	Phase
HY-N6687	Calcimycin		99.12%	Phase 4
HY-W105700	Ethylenediaminetetraacetic acid sodium hydrate		≥98.0%	Phase 4
HY-N6687A	Calcimycin hemicalcium salt		/	Phase 4
HY-N6687B	Calcimycin hemimagnesium		/	Phase 4
HY-103586	GS-441524	Inhibitor	99.77%	Phase 3
HY-142118	Trabedersen	Inhibitor	90.45%	Phase 3
HY-145728	Alicaforsen	Inhibitor	/	Phase 3
HY-149101	Riboxin		/	Phase 3
HY-P2141	TRV-120027	Agonist	99.46%	Phase 2
HY-P2141A	TRV-120027 TFA	Agonist	99.69%	Phase 2
HY-A0157B	Dimethothiazine hydrochloride	Antagonist	/	Phase 2
HY-P10515	AcrAP2	Inhibitor	/	Phase 2
HY-100973A	Adenosine 5′-diphosphoribose sodium		99.03%	Phase 1
HY-15533	LY 3000328	Inhibitor	98.00%	Phase 1
HY-103586A	GS-441524 hydrochloride	Inhibitor	/	Phase 1

Inhibitory Antibodies (2)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99305	Metelimumab	Inhibitor	≥95.0%	Phase 2
HY-P99474	Bertilimumab	Inhibitor	/	Phase 2

Pre-clinical Phase

Bioactive Molecules (151)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-13434	Ionomycin		≥99.0%	Unkown
HY-P1410	GsMTx4	Inhibitor	99.80%	Unkown
HY-101840	EIPA		99.73%	Unkown
HY-13434A	Ionomycin calcium		≥98.0%	Unkown
HY-P1410A	GsMTx4 TFA	Inhibitor	99.80%	Unkown
HY-146245	ODN 1826		/	Unkown
HY-152182	ML-SA5	Agonist	99.57%	Unkown
HY-129555	Surfactin	Inhibitor	98.96%	Unkown
HY-B1793	Tetraethylammonium chloride	Inhibitor	≥98.0%	Unkown
HY-P1471	Adrenomedullin (AM) (22-52), human	Antagonist	99.91%	Unkown
HY-101840A	EIPA hydrochloride		98.31%	Unkown
HY-14710	AZ3146	Inhibitor	99.92%	Unkown
HY-100231	Cathepsin inhibitor 1	Inhibitor	98.89%	Unkown
HY-19408	Pyr10	Inhibitor	99.42%	Unkown
HY-150726	ODN 1668	Agonist	/	Unkown
HY-19960	BCTC		98.03%	Unkown
HY-135869	Mito-apocynin (C11)	Inhibitor	99.24%	Unkown
HY-19976	RN-1747	Agonist	99.25%	Unkown
HY-W040129	Chromomycin A3	Inhibitor	99.66%	Unkown
HY-120601	Alizarin Red S sodium		≥95.0%	Unkown
HY-122605	TRPM4-IN-1	Inhibitor	99.98%	Unkown
HY-D0193	Ponceau 4R		99.09%	Unkown
HY-N1378	(E)-Cardamonin		99.84%	Unkown
HY-113469A	Cyclic GMP sodium		99.89%	Unkown
HY-107740	Pseudoisocyanine iodide	Inhibitor	99.92%	Unkown
HY-129096	IDT307		99.76%	Unkown
HY-146584	Cathepsin C-IN-5	Inhibitor	95.01%	Unkown
HY-110374	NVS-CECR2-1		99.40%	Unkown
HY-P2324	Gramicidin A	Inhibitor	98.1%	Unkown
HY-144256	CHD1Li 6.11	Inhibitor	99.54%	Unkown
HY-112776A	BN82002 hydrochloride	Inhibitor	99.36%	Unkown
HY-17630	Edasalonexent	Inhibitor	99.17%	Yes
HY-108460	A-784168	Inhibitor	≥99.0%	Unkown
HY-N6790	Nonactin		≥99.0%	Unkown
HY-P5601A	Thanatin TFA	Inhibitor	99.51%	Unkown
HY-131897	1-Stearoyl-2-arachidonoyl-sn-glycerol	Activator	≥99.0%	Unkown
HY-139192	NMDAR/TRPM4-IN-2		99.59%	Unkown
HY-N2003	D-Tetrahydropalmatine	Antagonist	99.84%	Unkown
HY-P1077A	CALP1 TFA		98.30%	Unkown
HY-W011972	Bromocholine bromide		≥98.0%	Unkown
HY-W014106	Tetraethylammonium tetrafluoroborate		≥95.0%	Unkown
HY-W018574	Tetraoctylammonium bromide		≥98.0%	Unkown
HY-107535	AS1269574		99.84%	Unkown
HY-135868	Mito-apocynin (C2)	Inhibitor	98.38%	Unkown
HY-P1770	Adrenomedullin (16-31), human		98.67%	Unkown
HY-121065	BN-82685	Inhibitor	99.05%	Unkown
HY-139192A	NMDAR/TRPM4-IN-2 free base		99.24%	Unkown
HY-149203A	MQA-P TFA		97.36%	Unkown
HY-P2887	Acetate kinase (ACK)		/	Unkown
HY-W006212	1,4,7-Triazonane		99.59%	Unkown
HY-W011052	Tetrapentylammonium bromide		≥98.0%	Unkown
HY-160610A	Carbamoyl phosphate dilithium salt		/	Unkown
HY-148129	TRPC6-IN-3	Inhibitor	99.62%	Unkown
HY-112776	BN82002	Inhibitor	/	Unkown
HY-W025784	Kalibor		≥99.0%	Unkown
HY-147774	Cathepsin K inhibitor 6	Inhibitor	98.18%	Unkown
HY-10656	SB-657510	Antagonist	99.84%	Unkown
HY-108446	GSK 1562590 hydrochloride	Antagonist	≥99.0%	Unkown
HY-114671	Taprostene	Agonist	/	Unkown
HY-117865	GNE-886	Inhibitor	99.81%	Unkown
HY-125870	Gellan gum, for cell culture		/	Unkown
HY-137155	Dapsone hydroxylamine	Inhibitor	/	Unkown
HY-B1221S1	Flufenamic acid-13C6		/	Unkown
HY-W011087	Benzyldimethyltetradecylammonium chloride		99.42%	Unkown
HY-W014536	N,N,N-Trimethyloctan-1-aminium chloride		≥99.0%	Unkown
HY-W127701	[Bmpip][NTf2]		≥97.0%	Unkown
HY-Y0682S	EDTA-d12		98.00%	Unkown
HY-158222	Alginate Methacryloyl (MW 50000)		/	Unkown
HY-100057	BMY 28674	Antagonist	/	Unkown
HY-10290	MK-0674	Inhibitor	/	Unkown
HY-103216A	RWJ52353 hydrochloride	Agonist	/	Unkown
HY-107129	MK-3577	Antagonist	/	Unkown
HY-107345	Droxicam		/	Unkown
HY-107644	AQ-RA 741	Antagonist	/	Unkown
HY-107756	LOE 908 hydrochloride	Inhibitor	/	Unkown
HY-111297	BMVC4		/	Unkown
HY-111525	Monactin	Inhibitor	/	Unkown
HY-113778	15-keto-17-phenyl trinor Prostaglandin F2α		/	Unkown
HY-116161	Bimatoprost isopropyl ester		/	Unkown
HY-117774	AHR-2244 hydrochloride		/	Unkown
HY-120685	WAY-125971	Antagonist	/	Unkown
HY-121670	Ambenoxan		/	Unkown
HY-121670A	Ambenoxan hydrochloride		/	Unkown
HY-124514	UC-857993	Inhibitor	/	Unkown
HY-126115	15(S)-Latanoprost		/	Unkown
HY-131897S	1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol	Activator	/	Unkown
HY-136894	Rhod-5N		/	Unkown
HY-143714	Cathepsin K inhibitor 2	Inhibitor	/	Unkown
HY-145150	TRPC5-IN-1	Inhibitor	/	Unkown
HY-146580	Cathepsin C-IN-3	Inhibitor	/	Unkown
HY-146581	Cathepsin C-IN-4	Inhibitor	/	Unkown
HY-147186	5,5'-Difluoro BAPTA		/	Unkown
HY-147333	Trimipramine N-oxide		/	Unkown
HY-148034	Plm IV inhibitor-1		/	Unkown
HY-148156	Hydroxydione		/	Unkown
HY-148162	Kayexalate		/	Unkown
HY-153613	Ac-PLVE-FMK	Inhibitor	≥98.0%	Unkown
HY-153614	Ac-VLPE-FMK	Inhibitor	≥99.0%	Unkown
HY-155254	Sodium ionophore VI		/	Unkown
HY-157441	AChE/Aβ-IN-4	Inhibitor	/	Unkown
HY-158222A	Alginate Methacryloyl (MW 300000)		/	Unkown
HY-161772	(S)-Gebr32a	Inhibitor	/	Unkown
HY-A0157	Dimethothiazine	Antagonist	/	Unkown
HY-A0157A	Dimethothiazine mesylate	Antagonist	/	Unkown
HY-B0565S	Ronidazole-d3		/	Unkown
HY-B1221S	Flufenamic acid-d4		/	Unkown
HY-D1640	5',5-Difluoro BAPTA tetrapotassium		/	Unkown
HY-E70373	λ Protein phosphatase		/	Unkown
HY-E70387	Ligninase		/	Unkown
HY-P10228	S-Thanatin	Inhibitor	/	Unkown
HY-P10652	hsBCL9CT-24	Inhibitor	/	Unkown
HY-P1077	CALP1		/	Unkown
HY-P1471A	Adrenomedullin (AM) (22-52), human TFA	Antagonist	/	Unkown
HY-P1770A	Adrenomedullin (16-31), human TFA		/	Unkown
HY-P2324A	Gramicidin A TFA	Inhibitor	/	Unkown
HY-P3711	SPAI-1	Inhibitor	/	Unkown
HY-P5601	Thanatin	Inhibitor	/	Unkown
HY-RS01982	CAT Human Pre-designed siRNA Set A	Pre-designed Sets	/	Unkown
HY-W010736A	1,2-Dipalmitoyl-rac-glycerol		/	Unkown
HY-W011122	Tributylbenzylammonium bromide		≥98.0%	Unkown
HY-W012450	Trimethylphenylammonium bromide		≥97.0%	Unkown
HY-W013231	N-Benzyl-N,N-diethylethanaminium iodide		/	Unkown
HY-W014408	Tetraethylammonium bromide		≥98.0%	Unkown
HY-W075836	Ferrocenylmethyltrimethylammonium iodide		/	Unkown
HY-W105699	EDTA tetrasodium tetrahydrate		≥97.0%	Unkown
HY-W127739	Zineb		/	Unkown
HY-Y0682S1	Ethylenediaminetetraacetic acid-d16		/	Unkown
HY-111527	PPZ2		/	Unkown
HY-115371	Butaperazine dimaleate		/	Unkown
HY-116264	CatB-IN-1		/	Unkown
HY-116478	L-3373		/	Unkown
HY-116889	15-Keto latanoprost acid		/	Unkown
HY-117817	Ranelic acid		/	Unkown
HY-124894	(+)-Benalaxyl	Inhibitor	/	Unkown
HY-126605	Trinactin	Inhibitor	/	Unkown
HY-126763	ATI22-107		/	Unkown
HY-129846	IBTP iodide		/	Unkown
HY-130325	α-Guanidinoglutaric acid		/	Unkown
HY-134268	8-Br-7-CH-ADPR	Antagonist	/	Unkown
HY-137639	Sp-8-Br-cGMPS	Agonist	/	Unkown
HY-139120	19(R)-hydroxy Prostaglandin E2		/	Unkown
HY-14830	SAR 97276	Inhibitor	/	Unkown
HY-157240	CEX Ion-exchange resin		/	Unkown
HY-157241	CEX Cation-exchange resin 1		/	Unkown
HY-157242	CEX Polishing resin		/	Unkown
HY-157243	CEX Cation-exchange resin 2		/	Unkown
HY-163073	Anti-MRSA agent 9	Inhibitor	/	Unkown
HY-D2319	Mito Flipper-TR 27		/	Unkown
HY-N8707	Homobutein	Inhibitor	/	Unkown
HY-W103463	1-Phenyl-2-pyrrolidinone	Inhibitor	99.86%	Unkown
HY-W781133	cDPCP		/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99695	Lerdelimumab	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Felis catus	CAT	NCBI	NCBI:101093891
Canis lupus familiaris	CAT	NCBI
Mus musculus	CAT	NCBI	NCBI:12359
Rattus norvegicus	CAT	NCBI	NCBI:24248